摘要
目的分析皮质下动脉硬化性脑病(SAE)患者血清hs-CRP测定的临床价值。方法 SAE患者90例为观察组,同期健康志愿者90例作为对照组,对比两组血清hs-CRP水平;患者按病情程度分为轻、中、重,对比观察各组间hs-CRP水平。结果观察组平均血清hs-CRP水平显著高于对照组,不同程度病情间的hs-CRP水平亦有明显差异,程度越严重指标水平越高,差异均有统计学意义(P<0.05)。结论 SAE患者血清hsCRP水平相比正常人明显升高,且随着病情发展程度而逐渐升高,与病情之间有着密切的关系。
Objective To study sigificance of CRP level in patients with subcortical arteriosclerotic encephalopathy(SAE). Methods 90 SAE patients and 90 health cases were included. Patients were divided into three subgroups: mild group, moderate group and severe group. Hs-CRP level was compared among these three subgroups. Results The serum hs-CRP level in SAE group were higher than it in the control group(P〈0.05). The significant difference were showed in different SAE subgroups(P〈0.05). Conclusion The serum level of hs-CRP was significantly higher in patients with SAE and was associated with disease severity.
出处
《中国处方药》
2014年第10期6-7,共2页
Journal of China Prescription Drug